Exelixis, Inc. (NASDAQ:EXEL) Receives $30.50 Consensus Target Price from Brokerages

Exelixis, Inc. (NASDAQ:EXEL – Get Rating) has received an average recommendation of “Buy” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, six have issued a buy rating and one has issued a strong buy […]

Related Keywords

Coreys Goodman ,Jeffrey Hessekiel ,Piper Sandler ,Patrickj Haley ,Huntington National Bank ,Cassady Schiller Wealth Management ,Exelixis Company Profile Get Rating ,Nasdaq ,Exelixis Inc ,Baillie Gifford Co ,Americas Holdings Corp ,Clarity Wealth Management Inc ,Get Rating ,Clarity Wealth Management ,National Bank ,Holdings Corp ,Company Profile ,Exelixis ,Nasdaq Exel ,Rexel ,Medical ,30161q10 ,Ratings ,Consensus ,